Document 2672 DOCN M94A2672 TI Rapid screening tests for HIV. DT 9412 AU Sciandra M; Brusa T; Lingua A; Sinicco A; Inst. of Infect. Dis., Univ. of Turin, Italy. SO Int Conf AIDS. 1994 Aug 7-12;10(1):250 (abstract no. PB0431). Unique Identifier : AIDSLINE ICA10/94369903 AB OBJECTIVE: to evaluate sensitivity and specificity of SeroCard HIV1 (SC1) and SeroCard HIV1/2 antibody test (SC1/2) (Trinity Biotech, Dublin, Ireland). METHODS: SC1 was used in 90 subjects; 36 were done in blind, 26 in HIV1+, 20 in healthy controls and 8 in subjects with undetermined ELISA. We used fresh whole blood. SC1/2 was used in 42 subjects; 14 were done in blind, 15 in HIV1+, 5 in black race HIV2+ subjects, 8 in healthy controls; 27 were done using sera, 15 using fresh whole blood. Contemporarly we performed ELISA test and WB. RESULTS: SC1: no false positive or negative result was observed. Among blind tests we saw 6 positive results, confirmed in ELISA and WB. All the 8 undetermined ELISA subjects resulted HIV1-for SC1 and WB.SC1/2: no false positive or negative result was observed. Among blind tests we saw 3 positive results confirmed in ELISA and WB. All the 5 HIV2+ subjects resulted positive for SC1/2 and negative for SC1. The total time require to perform the tests is about 7 minutes. CONCLUSION: SC1 and SC1/2 are useful kits for the rapid screening of subjects at risk for HIV1/2 in emergency departments, infectious diseases departments, prisons, etc. DE AIDS Serodiagnosis/*METHODS Blotting, Western Comparative Study Enzyme-Linked Immunosorbent Assay Human HIV Antibodies/*BLOOD HIV Seropositivity/*DIAGNOSIS/IMMUNOLOGY HIV-1/*IMMUNOLOGY HIV-2/*IMMUNOLOGY Mass Screening Predictive Value of Tests *Reagent Kits, Diagnostic MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).